Your browser doesn't support javascript.
loading
Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study.
Yang, Mei; Liu, Xuemei; Hu, Qiongqiong; Li, Junjie; Fu, Sijia; Chen, Daohong; Wu, Yanqing; Luo, Ai; Zhang, Xiawei; Feng, Ruizhi; Xu, Guo; Liu, Can; Jiang, Hongli; Liu, Wei.
Afiliación
  • Yang M; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Liu X; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Hu Q; Department of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Li J; West China School of Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Fu S; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Chen D; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Wu Y; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Luo A; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Zhang X; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Feng R; Respiratory Medicine Unit and National Institute for Health Research, Nuffield Department of Medicine Experimental Medicine, Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
  • Xu G; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Liu C; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Jiang H; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
  • Liu W; Division of Pulmonary Diseases, Department of Integrated Traditional and Western Medicine, Sichuan University West China Hospital, Chengdu, Sichuan, China.
BMJ Open ; 12(1): e051939, 2022 Jan 20.
Article en En | MEDLINE | ID: mdl-35058259
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_chronic_obstructive_pulmonary_disease / 6_other_respiratory_diseases Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Antibacterianos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_chronic_obstructive_pulmonary_disease / 6_other_respiratory_diseases Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Antibacterianos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Ethics Límite: Humans Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: China